Colorectal Cancer Screening Market Grows to USD 31.1 billion by 2034, Says Study

The Global Colorectal Cancer Screening Market is projected to grow from USD 15.5 billion in 2024 to USD 31.1 billion by 2034, registering a CAGR of 7.2%. In 2024, North America dominated the market, accounting for over 40.1% share with USD 6.2 billion in revenue. One of the primary growth drivers is the increasing global burden of colorectal cancer. As the number of cases continues to rise, there is a greater push from governments and healthcare organizations to improve early detection through routine screening.

Changing lifestyles are also contributing to the increased risk of colorectal cancer. Poor diets, sedentary habits, smoking, and alcohol consumption are now more common. These factors have raised public concern and awareness, encouraging people to take preventive measures. At the same time, updated screening guidelines now recommend starting screening at younger ages due to rising cases in adults under 50, further expanding the screening population.

Government support and public health initiatives are playing a key role in driving market growth. Many countries are implementing national screening programs that offer free or low cost testing to citizens. These programs aim to boost early diagnosis and lower death rates. Alongside this, advancements in screening technologies such as at-home test kits and non-invasive procedures are making it easier for people to participate in screening efforts.

The aging population is another long term growth factor. As more people live longer, the number of older adults at risk for colorectal cancer continues to increase. Since the disease is more common among individuals over 50, this demographic shift is creating sustained demand for screening. Overall, the market is expanding due to a combination of rising cancer rates, improved awareness, supportive policies, and technological innovation.

Colorectal Cancer Screening Market Size

Key Takeaways

  • In 2024, the global colorectal cancer screening market reached a valuation of USD 15.5 billion and is growing at a steady CAGR of 7.2%.
  • Analysts expect the market to double by 2034, projecting it will hit approximately USD 31.1 billion due to rising demand for early detection.
  • The screening test segment includes stool tests, colonoscopy, flexible sigmoidoscopy, and others, with colonoscopy leading the segment with 40.7% market share in 2024.
  • Among end-users, hospitals dominated the market with a 55.2% share in 2024, largely due to high patient inflow and advanced diagnostic facilities.
  • Regionally, North America held the largest share of the market at 40.1% in 2024, driven by awareness campaigns and favorable reimbursement policies.

Get sample report: https://market.us/report/colorectal-cancer-screening-market/request-sample/

Emerging Trends

  1. Earlier Screening Recommendations: Medical guidelines have recently changed to recommend colorectal cancer screening at a younger age. This update is in response to the rising number of cases in adults under 50. Early screening helps detect cancer in its initial stages, improving the chances of successful treatment.
  2. Growth in At-Home Testing Kits: At-home colorectal cancer screening kits are becoming more popular. These kits are delivered to your home, easy to complete, and mailed back for lab analysis. They offer a convenient, non-invasive alternative for people who may avoid clinic-based tests.
  3. Advancement of Blood-Based Screening: New blood tests are being developed to identify early signs of colorectal cancer. These tests look for genetic or molecular changes in the bloodstream and are less invasive than procedures like colonoscopies or stool tests.
  4. AI Integration in Colonoscopy Procedures: Artificial intelligence (AI) is now being used during colonoscopies to assist doctors in identifying polyps or abnormal growths. AI systems act as a second observer, improving accuracy and reducing the chance of missed detections.
  5. Improved Screening for High-Risk Individuals: There’s a growing focus on enhancing screening strategies for individuals at higher risk such as those with a family history of colorectal cancer or conditions like inflammatory bowel disease. New genetic and molecular diagnostic tools are being developed to better serve these groups.

Use Cases

  1. National Screening Programs Expand Outreach: Many countries have introduced nationwide colorectal cancer screening initiatives aimed at boosting participation. These programs often involve sending test kits directly to individuals’ homes and issuing regular reminders, making it easier for people to stay on track with recommended screening schedules.
  2. Increased Screening Among Younger Adults: Growing awareness about early onset colorectal cancer is leading more adults under 50 to get screened. This is a crucial shift, as younger populations are seeing a noticeable rise in diagnoses compared to previous decades.
  3. Integration of AI in Clinical Settings: Hospitals and clinics are adopting artificial intelligence tools to support colonoscopy procedures. These systems assist doctors by identifying tiny polyps or abnormal tissue, increasing the accuracy and reliability of early cancer detection.
  4. Blood-Based Tests Offer Greater Convenience: For those who prefer a less invasive option, new blood-based screening tests are gaining popularity. These can often be performed during regular doctor visits and are especially useful for individuals with busy schedules or screening hesitancy.
  5. Smartphone Compatible Screening Innovations: Innovative tools that connect with smartphones are being piloted to enable self-screening at home. This approach is particularly beneficial in remote or underserved regions, where access to healthcare facilities is limited.

Conclusion

The colorectal cancer screening market is growing steadily due to rising awareness, supportive healthcare policies, and better technology. More people are now getting screened early, especially younger adults and high-risk groups. Tools like AI-assisted colonoscopies, at-home kits, and blood-based tests are making screening easier and more accurate. Governments and healthcare providers are also working hard to make screening more accessible through national programs. With lifestyle changes and an aging population adding to the risk, regular screening is becoming a vital part of preventive healthcare. Overall, the market is expanding because people are becoming more proactive about early cancer detection and are choosing more convenient and reliable screening options.

Contact us on
Market.us (Powered By Prudour Pvt. Ltd.)
Email: inquiry@market.us
Address: 420 Lexington Avenue, Suite 300,
New York City, NY 10170, United States
Tel: +1 718 618 4351

Comments

Post a Comment

Popular posts from this blog

Coagulation Analyzer Market Expected to Reach USD 8 Billion by 2034 With 5.3% CAGR Growth

Image
  Overview June 04, 2025 – The Global Coagulation Analyzer Market is poised for steady growth. It is projected to increase from USD 4.8 billion in 2024 to around USD 8.0 billion by 2034. This represents a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2034. This growth is driven by a rising demand for precise diagnostic tools, particularly in managing blood-related disorders. The importance of coagulation analyzers is reinforced by their inclusion in the World Health Organization’s Model List of Essential In Vitro Diagnostics. This endorsement signals their critical role in disease diagnosis and treatment monitoring on a global scale. The prevalence of blood disorders such as hemophilia, deep vein thrombosis, and clotting abnormalities is increasing worldwide. These conditions require timely and accurate diagnosis to prevent complications. Coagulation analyzers are essential in diagnosing these disorders and in monitoring patients undergoing ...
Read more

Smart Fitness APPs Market Poised for USD 8.0 Billion Growth by 2033, Says Industry Forecast

Image
 The Global Smart Fitness Apps Market is projected to grow from USD 2.1 billion in 2023 to around USD 8.0 billion by 2033. This reflects a strong CAGR of 18.4% during the forecast period (2024–2033). One major factor behind this growth is the rising awareness about health and wellness. People today understand the risks of a sedentary lifestyle and are seeking convenient ways to stay active. According to the World Health Organization, regular physical activity can reduce the risk of many chronic diseases. Fitness apps offer a simple, accessible solution—users can track workouts, set goals, and monitor progress directly from their smartphones. The widespread use of smartphones and fitness wearables is boosting app adoption further. Many of these apps connect easily with smartwatches and bands, allowing users to monitor steps, calories burned, heart rate, and sleep quality. This seamless integration encourages daily use and supports consistent fitness habits. Additionally, public ...
Read more

Proteomics Market Growth Accelerates with Rising Focus on Targeted Disease Therapies

Image
  Overview 18 June 2025 –The global proteomics market is expected to reach USD 103.8 billion by 2032, rising from USD 26.8 billion in 2022. This rapid growth is due to increasing demand for personalized medicine. Healthcare systems worldwide are focusing more on individual-based treatments. Proteomics plays a key role in identifying protein changes linked to specific diseases. With support from national governments and international agencies, research in this field is expanding. These efforts help develop therapies tailored to patients’ unique biological profiles, leading to more effective outcomes. Technological advancements in proteomics are accelerating market growth. Tools like mass spectrometry and high-throughput screening have improved the speed and accuracy of protein analysis. Government health bodies and public research institutes are investing in these technologies. As a result, hospitals and labs can better study diseases at the molecular level. This leads to more pr...
Read more